Effects of telomerase activity and apoptosis on ex vivo expansion of cord blood CD34+ cells

Cell Proliferation

Volumn 46, Issue 1, 2013, Pages 38-44

  Ge, J ^a   Cai, H ^a   Li, Q ^b   Du, Z ^a   Tan, W S ^a  

^a EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b GUANGXI UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; MESSENGER RNA; SURVIVIN; TELOMERASE;

APOPTOSIS; ARTICLE; BIOLOGICAL MONITORING; CELL DIFFERENTIATION; CELL EXPANSION; CELL ISOLATION; CELL POPULATION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EX VIVO STUDY; FLOW CYTOMETRY; GROWTH RATE; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UMBILICAL CORD BLOOD;

ANTIGENS, CD34; APOPTOSIS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; FETAL BLOOD; HUMANS; RNA, MESSENGER; TELOMERASE;

EID: 84871988321     PISSN: 09607722     EISSN: 13652184     Source Type: Journal    
DOI: 10.1111/cpr.12006     Document Type: Article

References (30)

1. Rubinstein P, Carrier C, Scaradavou A, Kurtzberg J, Adamson J, Migliaccio AR, et al. (1998) Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N. Engl. J. Med. 339, 1565-1577.
2. Wagner J, Barker J, DeFor T, Baker KS, Blazar BR, Eide C, et al. (2002) Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood 100, 1611-1618.
3. Forraz N, McGuckin CP (2011) The umbilical cord: a rich and ethical stem cell source to advance regenerative medicine. Cell Prolif. 44(Suppl. 1), 60-69.
4. Laughlin M, Barker J, Bambach B, Koc ON, Rizzieri DA, Wagner JE, et al. (2001) Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N. Engl. J. Med. 344, 1815-1822.
5. Grewal S, Barker J, Davies S, Wagner J (2003) Unrelated donor hematopoietic cell transplantation: marrow or umbilical cord blood. Blood 101, 4233-4244.
6. Jaroscak J, Goltry K, Smith A, Waters-Pick B, Martin PL, Driscoll TA, et al. (2003) Augmentation of umbilical cord blood (UCB) transplantation with ex vivo-expanded UCB cells: results of a phase 1 trial using the AastromReplicell System. Blood 101, 5061-5067.
7. Dahlberg A, Delaney C, Bernstein ID (2011) Ex vivo expansion of human hematopoietic stem and progenitor cells. Blood 117, 6083-6090.
8. Gammaitoni L, Weisel K, Gunetti M, Wu KD, Bruno S, Pinelli S, et al. (2004) Elevated telomerase activity and minimal telomere loss in cord blood long-term cultures with extensive stem cell replication. Blood 103, 4440-4448.
9. Li S, Crothers J, Haqq C, Blackburn E (2005) Cellular and gene expression responses involved in the rapid growth inhibition of human cancer cells by RNA interference-mediated depletion of telomerase RNA. J. Biol. Chem. 280, 23709-23717.
10. Reed S (1992) The role of p34 kinases in the G1 to S-phase transition. Annu. Rev. Cell Biol. 8, 529-561.
11. Engelhardt M, Kumar R, Albanell J, Pettengell R, Han W, Moore M (1997) Telomerase regulation, cell cycle, and telomere stability in primitive hematopoietic cells. Blood 90, 182-193.
12. Buchkovich K, Duffy L, Harlow E (1989) The retinoblastoma protein is phosphorylated during specific phases of the cell cycle. Cell 58, 1097-1105.
13. Broek D, Bartlett R, Crawford K, Nurse P (1991) Involvement of p34cdc2 in establishing the dependency of S phase on mitosis. Nature 349, 388-393.
14. Zhao YM, Li JY, Lan JP, Lai XY, Luo Y, Sun J, et al. (2008) Cell cycle dependent telomere regulation by telomerase in human bone marrow mesenchymal stem cells. Biochem. Biophys. Res. Commun. 369, 1114-1119.
15. Jaras M, Edqvist A, Rebetz J, Salford L, Widegren B, Fan X (2006) Human short-term repopulating cells have enhanced telomerase reverse transcriptase expression. Blood 108, 1084-1091.
16. King K, Cidlowski J (1998) Cell cycle regulation and apoptosis. Annu. Rev. Physiol. 60, 601-617.
17. Schuurhuis G, Muijen M, Oberink J, De Boer F, Ossenkoppele G, Broxterman H (2001) Large populations of non-clonogenic early apoptotic CD34-positive cells are present in frozen-thawed peripheral blood stem cell transplants. Bone Marrow Transplant. 27, 487-498.
18. De Boer F, Drager A, Pinedo H, Kessler F, Monnee-van Muijen M, Weijers G, et al. (2002) Early apoptosis largely accounts for functional impairment of CD34 + cells in frozen-thawed stem cell grafts. J. Hematother. Stem Cell Res. 11, 951-963.
19. Mastino A, Favalli C, Camilli A, Malerba C, Grelli S, Calugi A (2003) Umbilical cord blood: the role of apoptosis in the control of CD34 + cell counts. Placenta 24, 113-115.
20. Shim J, Cho B, Kim M, Park G, Shin J, Hwang H, et al. (2006) Early apoptosis in CD34 cells as a potential heterogeneity in quality of cryopreserved umbilical cord blood. Br. J. Haematol. 135, 210-213.
21. Wulf-Goldenberg A, Eckert K, Fichtner I (2008) Cytokine-pretreatment of CD34 + cord blood stem cells in vitro reduces long-term cell engraftment in NOD/SCID mice. Eur. J. Cell Biol. 87, 69-80.
22. Blagosklonny M (2003) Apoptosis, proliferation, differentiation: in search of the order. Semin. Cancer Biol. 13, 97-105.
23. Masutomi K, Yu E, Khurts S, Ben-Porath I, Currier J, Metz G, et al. (2003) Telomerase maintains telomere structure in normal human cells. Cell 114, 241-253.
24. Tomlinson R, Ziegler T, Supakorndej T, Terns R, Terns M (2006) Cell cycle-regulated trafficking of human telomerase to telomeres. Mol. Biol. Cell 17, 955.
25. Sloand E, Pfannes L, Chen G, Shah S, Solomou EE, Barrett J, et al. (2007) CD34 cells from patients with trisomy 8 myelodysplastic syndrome (MDS) express early apoptotic markers but avoid programmed cell death by up-regulation of antiapoptotic proteins. Blood 109, 2399-2405.
26. Tamm I, Wang Y, Sausville E, Scudiero DA, Vigna N, Oltersdorf T, et al. (1998) IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs. Cancer Res. 58, 5315-5320.
27. Shin S, Sung B, Cho Y, Kim HJ, Ha NC, Hwang JI, et al. (2001) An anti-apoptotic protein human survivin is a direct inhibitor of caspase-3 and-7. Biochemistry 40, 1117-1123.
28. Xing Z, Conway E, Kang C, Winoto A (2004) Essential role of survivin, an inhibitor of apoptosis protein, in T cell development, maturation, and homeostasis. J. Exp. Med. 199, 69-80.
29. Gurbuxani S, Xu Y, Keerthivasan G, Wickrema A, Crispino J (2005) Differential requirements for survivin in hematopoietic cell development. PNAS 102, 11480-11485.
30. Hoggatt J, Singh P, Sampath J, Pelus LM (2009) Prostaglandin E2 enhances hematopoietic stem cell homing, survival, and proliferation. Blood 113, 5444-5455.